{"id":9682,"date":"2026-03-19T16:44:56","date_gmt":"2026-03-19T08:44:56","guid":{"rendered":"https:\/\/regask.com\/?p=9682"},"modified":"2026-03-19T16:46:03","modified_gmt":"2026-03-19T08:46:03","slug":"la-fda-de-ee-uu-presenta-aems-una-plataforma-unificada-para-la-notificacion-de-eventos-adversos-y-la-vigilancia-de-la-seguridad","status":"publish","type":"post","link":"https:\/\/regask.com\/es\/u-s-fda-introduces-aems-a-unified-platform-for-adverse-event-reporting-and-safety-surveillance\/","title":{"rendered":"La FDA de EE. UU. presenta AEMS: una plataforma unificada para la prevenci\u00f3n de ataques\u2026"},"content":{"rendered":"<p><span class=\"TextRun SCXW130125533 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW130125533 BCX0\">En <\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW130125533 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW130125533 BCX0\">11 de marzo de 2026<\/span><\/span><span class=\"TextRun SCXW130125533 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW130125533 BCX0\">, el\u00a0<\/span><\/span><span class=\"TextRun MacChromeBold SCXW130125533 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW130125533 BCX0\">Administraci\u00f3n de Alimentos y Medicamentos de los Estados Unidos (FDA)<\/span><\/span><\/strong><span class=\"TextRun SCXW130125533 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW130125533 BCX0\">\u00a0introdujo el<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW130125533 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW130125533 BCX0\">Sistema de Monitoreo de Eventos Adversos (AEMS)<\/span><\/span><\/strong><span class=\"TextRun SCXW130125533 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW130125533 BCX0\"><strong>,<\/strong> una plataforma centralizada dise\u00f1ada para optimizar la notificaci\u00f3n de eventos adversos en todos los \u00e1mbitos.\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW130125533 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW130125533 BCX0\">Categor\u00edas de productos regulados por la FDA<\/span><\/span><\/strong><span class=\"TextRun SCXW130125533 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW130125533 BCX0\"><strong>.<\/strong> El sistema afecta a las partes interesadas involucradas en\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW130125533 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW130125533 BCX0\">farmacovigilancia, notificaci\u00f3n de seguridad y cumplimiento normativo<\/span><\/span><\/strong><span class=\"TextRun SCXW130125533 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW130125533 BCX0\"><strong>,<\/strong> que abarca sectores como productos m\u00e9dicos, vacunas, dispositivos m\u00e9dicos, tabaco, alimentos, cosm\u00e9ticos y medicamentos veterinarios.<\/span><\/span><span class=\"EOP SCXW130125533 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<div class=\"row\"  id=\"row-777160498\">\n\n\t<div id=\"col-1902893891\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div id=\"gap-766323591\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-766323591 {\n  padding-top: 20px;\n}\n<\/style>\n\t<\/div>\n\t\n<h2>Detalles de la actualizaci\u00f3n<\/h2>\n\t<div id=\"gap-1886006274\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1886006274 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span data-contrast=\"auto\">El reci\u00e9n lanzado\u00a0<\/span><b><span data-contrast=\"auto\">AEMS<\/span><\/b><span data-contrast=\"auto\">\u00a0reemplaza varios sistemas de informes heredados con un\u00a0<\/span><b><span data-contrast=\"auto\">plataforma \u00fanica y unificada<\/span><\/b><span data-contrast=\"auto\">, lo que permite protocolos de env\u00edo estandarizados y una mayor coherencia de los datos en todas las categor\u00edas de productos. Introduce\u00a0<\/span><b><span data-contrast=\"auto\">Flujos de trabajo avanzados para el procesamiento de casos<\/span><\/b><span data-contrast=\"auto\">\u00a0apoyado por\u00a0<\/span><b><span data-contrast=\"auto\">herramientas de redacci\u00f3n y digitalizaci\u00f3n basadas en inteligencia artificial<\/span><\/b><span data-contrast=\"auto\">, mejorando la eficiencia y la calidad de los informes presentados.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">El sistema tambi\u00e9n fortalece\u00a0<\/span><b><span data-contrast=\"auto\">capacidades de vigilancia entre productos<\/span><\/b><span data-contrast=\"auto\">\u00a0a trav\u00e9s de an\u00e1lisis mejorados, lo que permite a los reguladores y las partes interesadas identificar patrones y se\u00f1ales en diferentes tipos de productos. Adem\u00e1s de la notificaci\u00f3n de eventos adversos, AEMS brinda soporte\u00a0<\/span><b><span data-contrast=\"auto\">quejas de consumidores, informes de mala conducta regulatoria y denuncias de informantes<\/span><\/b><span data-contrast=\"auto\">, ampliando el alcance de la vigilancia de la seguridad.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Una caracter\u00edstica clave del sistema es la\u00a0<\/span><b><span data-contrast=\"auto\">Panel p\u00fablico de AEMS<\/span><\/b><span data-contrast=\"auto\">, que proporciona a las partes interesadas\u00a0<\/span><b><span data-contrast=\"auto\">Acceso con posibilidad de b\u00fasqueda a los eventos adversos notificados<\/span><\/b><span data-contrast=\"auto\">. Si bien esto promueve la transparencia y la usabilidad, la FDA enfatiza que los datos reportados\u00a0<\/span><b><span data-contrast=\"auto\">puede contener informaci\u00f3n duplicada o incompleta<\/span><\/b><span data-contrast=\"auto\">\u00a0y\u00a0<\/span><b><span data-contrast=\"auto\">No establece causalidad, tasas de incidencia ni perfiles definitivos de seguridad del producto.<\/span><\/b><span data-contrast=\"auto\">.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1902893891 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1583053164\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Por qu\u00e9 es importante<\/h2>\n\t<div id=\"gap-191761341\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-191761341 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW91408954 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW91408954 BCX0\">La implementaci\u00f3n de\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW91408954 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW91408954 BCX0\">AEMS<\/span><\/span><\/strong><span class=\"TextRun SCXW91408954 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW91408954 BCX0\">\u00a0mejora\u00a0<\/span><\/span><span class=\"TextRun MacChromeBold SCXW91408954 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW91408954 BCX0\"><strong>eficiencia regulatoria y datos<\/strong> <strong>integraci\u00f3n<\/strong><\/span><\/span><span class=\"TextRun SCXW91408954 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW91408954 BCX0\">\u00a0por\u00a0<\/span><span class=\"NormalTextRun SCXW91408954 BCX0\">consolidando<\/span><span class=\"NormalTextRun SCXW91408954 BCX0\">\u00a0sistemas de informes dispares en un marco unificado. El uso de\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW91408954 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW91408954 BCX0\">Herramientas con inteligencia artificial y flujos de trabajo estandarizados<\/span><\/span><\/strong><span class=\"TextRun SCXW91408954 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW91408954 BCX0\">\u00a0admite una mejor calidad de datos y detecci\u00f3n de se\u00f1ales, mientras que el panel p\u00fablico se alinea con objetivos m\u00e1s amplios de\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW91408954 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW91408954 BCX0\">transparencia y accesibilidad digital<\/span><\/span><\/strong><span class=\"TextRun SCXW91408954 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW91408954 BCX0\"><strong>.<\/strong> En general, el sistema est\u00e1 dise\u00f1ado para fortalecer la supervisi\u00f3n de la seguridad del ciclo de vida, mientras que\u00a0<\/span><span class=\"NormalTextRun SCXW91408954 BCX0\">manteniendo<\/span><span class=\"NormalTextRun SCXW91408954 BCX0\">\u00a0a\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW91408954 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW91408954 BCX0\">baja carga administrativa<\/span><\/span><\/strong><span class=\"TextRun SCXW91408954 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW91408954 BCX0\">\u00a0para las partes interesadas.<\/span><\/span><span class=\"EOP SCXW91408954 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1583053164 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1522590015\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Para qui\u00e9n es relevante<\/h2>\n\t<div id=\"gap-2111712376\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-2111712376 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Esta actualizaci\u00f3n es relevante para los profesionales en <strong>Asuntos regulatorios, farmacovigilancia, garant\u00eda de calidad, cumplimiento y equipos de TI,<\/strong> particularmente aquellos responsables de <strong>Notificaci\u00f3n de eventos adversos, gesti\u00f3n de datos de seguridad y presentaciones regulatorias.<\/strong> en todas las industrias reguladas por la FDA.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1522590015 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-2056253174\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Pr\u00f3ximos pasos<\/h2>\n\t<div id=\"gap-1310839038\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1310839038 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span data-contrast=\"auto\">Las organizaciones deber\u00edan\u00a0<\/span><b><span data-contrast=\"auto\">Revisar la funcionalidad de la plataforma AEMS.<\/span><\/b><span data-contrast=\"auto\">\u00a0y evaluar c\u00f3mo se alinean los flujos de trabajo de informes actuales con el nuevo sistema consolidado. Equipos responsables de\u00a0<\/span><b><span data-contrast=\"auto\">Notificaci\u00f3n de eventos adversos y gesti\u00f3n de quejas<\/span><\/b><span data-contrast=\"auto\">\u00a0Se les anima a familiarizarse con el\u00a0<\/span><b><span data-contrast=\"auto\">capacidades de consulta del panel p\u00fablico<\/span><\/b><span data-contrast=\"auto\">\u00a0y monitorear las actualizaciones en curso. Con el tiempo, las partes interesadas pueden considerar\u00a0<\/span><b><span data-contrast=\"auto\">Adaptaci\u00f3n de los procesos internos de gesti\u00f3n de datos y monitorizaci\u00f3n de se\u00f1ales.<\/span><\/b><span data-contrast=\"auto\">\u00a0para aprovechar un mejor acceso a informaci\u00f3n sobre seguridad aplicable a diferentes productos.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">A medida que los sistemas regulatorios contin\u00faan evolucionando hacia\u00a0<\/span><b><span data-contrast=\"auto\">plataformas centralizadas con capacidad de IA<\/span><\/b><span data-contrast=\"auto\">, soluciones como\u00a0<\/span><a href=\"http:\/\/regask.com\/es\/\"><b><span data-contrast=\"auto\">RegASK<\/span><\/b><\/a><span data-contrast=\"auto\">\u00a0puede ayudar a las organizaciones a anticiparse a estos cambios.\u00a0<a href=\"http:\/\/regask.com\/es\/\"><strong>RegASK<\/strong><\/a>\u00a0Es una plataforma l\u00edder de inteligencia regulatoria y orquestaci\u00f3n de flujos de trabajo con IA agentic que permite a organizaciones globales en sectores altamente regulados, como productos de consumo y ciencias de la vida, gestionar de forma proactiva entornos regulatorios complejos. Al combinar IA agentic avanzada con expertos en el sector,\u00a0<a href=\"http:\/\/regask.com\/es\/\"><strong>RegASK<\/strong><\/a>\u00a0Ofrece informaci\u00f3n predictiva y pr\u00e1ctica en tiempo real, as\u00ed como automatizaci\u00f3n integral, lo que agiliza los procesos de cumplimiento, mitiga los riesgos y acelera el acceso al mercado en m\u00e1s de 160 pa\u00edses.<strong><a href=\"http:\/\/regask.com\/es\/\"> M\u00e1s informaci\u00f3n<\/a> o <a href=\"https:\/\/regask.com\/es\/reservar-una-demostracion\/\">Reserve una demostraci\u00f3n ahora.<\/a><\/strong><\/span><strong>\u00a0<\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-2056253174 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n<div class=\"row\"  id=\"row-1589856157\">\n\n\t<div id=\"col-225322225\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<div class=\"is-divider divider clearfix\" style=\"margin-top:2em;margin-bottom:2em;max-width:20%;height:1px;background-color:#a5acd9;\"><\/div>\n<h3>Preguntas frecuentes<\/h3>\n\t<div id=\"gap-1074313445\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1074313445 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<h4><span class=\"TextRun MacChromeBold SCXW179543514 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW179543514 BCX0\">\u00bfQu\u00e9 es el Sistema de Monitoreo de Eventos Adversos (AEMS) de la FDA?<\/span><\/span><span class=\"EOP SCXW179543514 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-1500962099\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1500962099 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>El <strong>AEMS<\/strong> Es una plataforma centralizada lanzada por la FDA para gestionar la notificaci\u00f3n de eventos adversos en todas las categor\u00edas de productos reguladas por la FDA.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-225322225 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-433064902\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4><span class=\"TextRun MacChromeBold SCXW250270229 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW250270229 BCX0\">\u00bfQu\u00e9 tipos de informes gestiona AEMS?<\/span><\/span><span class=\"EOP SCXW250270229 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-2014191555\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-2014191555 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>El sistema admite <strong>informes de eventos adversos, quejas de consumidores, informes de mala conducta regulatoria y denuncias de informantes. <\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-433064902 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-426388187\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4><span class=\"TextRun MacChromeBold SCXW232842177 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW232842177 BCX0\">\u00bfSe pueden utilizar los datos de AEMS para...?\u00a0<\/span><span class=\"NormalTextRun SCXW232842177 BCX0\">determinar<\/span><span class=\"NormalTextRun SCXW232842177 BCX0\">\u00a0\u00bfSeguridad del producto o causalidad?<\/span><\/span><span class=\"EOP SCXW232842177 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-777121134\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-777121134 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>No. La FDA afirma que los datos de AEMS <strong>no establece causalidad, tasas de incidencia ni perfiles de seguridad definitivos,<\/strong> y puede incluir informes incompletos o duplicados.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-426388187 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1336082215\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4><span class=\"TextRun MacChromeBold SCXW252578696 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW252578696 BCX0\">\u00bfC\u00f3mo puedo?\u00a0<\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW252578696 BCX0\">RegASK<\/span><span class=\"NormalTextRun SCXW252578696 BCX0\">\u00a0\u00bfAyudar a las organizaciones a adaptarse a AEMS?<\/span><\/span><span class=\"EOP SCXW252578696 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-666316064\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-666316064 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW213849445 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><strong><a href=\"http:\/\/regask.com\/es\/\"><span class=\"NormalTextRun SpellingErrorV2Themed SCXW213849445 BCX0\">RegASK<\/span><\/a><\/strong><span class=\"NormalTextRun SCXW213849445 BCX0\">\u00a0ayuda a las organizaciones\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW213849445 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW213849445 BCX0\">monitor<\/span><span class=\"NormalTextRun SCXW213849445 BCX0\">\u00a0actualizaciones regulatorias, agilizar los flujos de trabajo de cumplimiento y\u00a0<\/span><span class=\"NormalTextRun SCXW213849445 BCX0\">aprovechar<\/span><span class=\"NormalTextRun SCXW213849445 BCX0\">\u00a0Informaci\u00f3n basada en inteligencia artificial<\/span><\/span><\/strong><span class=\"TextRun SCXW213849445 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW213849445 BCX0\"><strong>,<\/strong> permitir una adaptaci\u00f3n m\u00e1s eficiente a sistemas como AEMS y mejorar las pr\u00e1cticas de gesti\u00f3n de datos de seguridad.<\/span><\/span><span class=\"EOP SCXW213849445 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1336082215 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>","protected":false},"excerpt":{"rendered":"<p>El 11 de marzo de 2026, la Administraci\u00f3n de Alimentos y Medicamentos de los Estados Unidos (FDA) present\u00f3 el Sistema de Monitoreo de Eventos Adversos (AEMS, por sus siglas en ingl\u00e9s), una plataforma centralizada dise\u00f1ada para agilizar la notificaci\u00f3n de eventos adversos en todas las categor\u00edas de productos reguladas por la FDA. El sistema afecta a las partes interesadas en farmacovigilancia, notificaci\u00f3n de seguridad y cumplimiento normativo, abarcando sectores como productos m\u00e9dicos, vacunas, dispositivos m\u00e9dicos, tabaco, alimentos, cosm\u00e9ticos y medicamentos veterinarios.\u00a0<\/p>","protected":false},"author":43,"featured_media":9684,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[527,33,34],"tags":[],"class_list":["post-9682","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-united-states-regulations","category-news","category-food-beverage-insights"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>U.S. FDA Introduces AEMS: Revolutionizing Reporting<\/title>\n<meta name=\"description\" content=\"Learn about the U.S. FDA&#039;s new AEMS platform for adverse event reporting and its impact on safety surveillance practices.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/es\/la-fda-de-ee-uu-presenta-aems-una-plataforma-unificada-para-la-notificacion-de-eventos-adversos-y-la-vigilancia-de-la-seguridad\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"U.S. FDA Introduces AEMS: A Unified Platform for Adverse Event Reporting and Safety Surveillance\" \/>\n<meta property=\"og:description\" content=\"Learn about the U.S. FDA&#039;s new AEMS platform for adverse event reporting and its impact on safety surveillance practices.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/es\/la-fda-de-ee-uu-presenta-aems-una-plataforma-unificada-para-la-notificacion-de-eventos-adversos-y-la-vigilancia-de-la-seguridad\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-19T08:44:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-19T08:46:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/us-fda-introduces-aems-unified-platform-adverse-event-reporting-safety-surveillance.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Reva Ananda\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Reva Ananda\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/u-s-fda-introduces-aems-a-unified-platform-for-adverse-event-reporting-and-safety-surveillance\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/u-s-fda-introduces-aems-a-unified-platform-for-adverse-event-reporting-and-safety-surveillance\\\/\"},\"author\":{\"name\":\"Reva Ananda\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\"},\"headline\":\"U.S. FDA Introduces AEMS: A Unified Platform for Advers&hellip;\",\"datePublished\":\"2026-03-19T08:44:56+00:00\",\"dateModified\":\"2026-03-19T08:46:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/u-s-fda-introduces-aems-a-unified-platform-for-adverse-event-reporting-and-safety-surveillance\\\/\"},\"wordCount\":757,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/u-s-fda-introduces-aems-a-unified-platform-for-adverse-event-reporting-and-safety-surveillance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/us-fda-introduces-aems-unified-platform-adverse-event-reporting-safety-surveillance.png\",\"articleSection\":[\"United States\",\"Regulatory News\",\"Food and Nutrition\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/u-s-fda-introduces-aems-a-unified-platform-for-adverse-event-reporting-and-safety-surveillance\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/u-s-fda-introduces-aems-a-unified-platform-for-adverse-event-reporting-and-safety-surveillance\\\/\",\"name\":\"U.S. FDA Introduces AEMS: Revolutionizing Reporting\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/u-s-fda-introduces-aems-a-unified-platform-for-adverse-event-reporting-and-safety-surveillance\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/u-s-fda-introduces-aems-a-unified-platform-for-adverse-event-reporting-and-safety-surveillance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/us-fda-introduces-aems-unified-platform-adverse-event-reporting-safety-surveillance.png\",\"datePublished\":\"2026-03-19T08:44:56+00:00\",\"dateModified\":\"2026-03-19T08:46:03+00:00\",\"description\":\"Learn about the U.S. FDA's new AEMS platform for adverse event reporting and its impact on safety surveillance practices.\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/u-s-fda-introduces-aems-a-unified-platform-for-adverse-event-reporting-and-safety-surveillance\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/u-s-fda-introduces-aems-a-unified-platform-for-adverse-event-reporting-and-safety-surveillance\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/us-fda-introduces-aems-unified-platform-adverse-event-reporting-safety-surveillance.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/us-fda-introduces-aems-unified-platform-adverse-event-reporting-safety-surveillance.png\",\"width\":800,\"height\":600,\"caption\":\"Us Fda Introduces Aems Unified Platform Adverse Event Reporting Safety Surveillance\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@RegASK\",\"https:\\\/\\\/www.crunchbase.com\\\/organization\\\/regask\",\"https:\\\/\\\/www.bloomberg.com\\\/profile\\\/company\\\/1691237D:SP\",\"https:\\\/\\\/pitchbook.com\\\/profiles\\\/company\\\/265004-02\",\"https:\\\/\\\/www.cbinsights.com\\\/company\\\/RegASK\",\"https:\\\/\\\/vimeo.com\\\/RegASK\"],\"legalName\":\"RegASK PTE. LTD.\",\"foundingDate\":\"2018\",\"slogan\":\"Empowering Smarter Regulatory Decisions\",\"description\":\"Agentic AI regulatory intelligence and workflow orchestration platform for Life Sciences and Consumer Products. RegASK combines vertical LLMs, multi-agent AI architecture, and a global community of 1,800+ subject matter experts to deliver regulatory horizon scanning, impact analysis, compliance workflow automation, and audit-ready outputs across 160+ countries.\",\"areaServed\":\"Worldwide\",\"founder\":{\"@type\":\"Person\",\"name\":\"Caroline Shleifer\",\"jobTitle\":\"Founder & CEO\"},\"address\":{\"@type\":\"PostalAddress\",\"streetAddress\":\"79 Science Park Drive, #06-01, Cintech IV\",\"addressLocality\":\"Singapore\",\"postalCode\":\"118264\",\"addressCountry\":\"SG\"},\"contactPoint\":{\"@type\":\"ContactPoint\",\"telephone\":\"+65 6817 6290\",\"contactType\":\"customer service\",\"availableLanguage\":[\"English\",\"French\",\"Japanese\",\"Spanish\",\"Chinese\",\"German\"]},\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":50,\"maxValue\":100},\"knowsAbout\":[\"Regulatory Intelligence\",\"Regulatory Compliance\",\"Regulatory Affairs\",\"Workflow Orchestration\",\"Life Sciences Regulation\",\"Consumer Products Regulation\",\"AI-Driven Compliance\"],\"hasCertification\":[{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 42001:2023\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27001:2022\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27701\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27018:2019\"},{\"@type\":\"Certification\",\"name\":\"SOC 2 Type II\"}]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\",\"name\":\"Reva Ananda\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"La FDA de EE. UU. presenta AEMS: una revoluci\u00f3n en la presentaci\u00f3n de informes.","description":"Conozca la nueva plataforma AEMS de la FDA de EE. UU. para la notificaci\u00f3n de eventos adversos y su impacto en las pr\u00e1cticas de vigilancia de la seguridad.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/es\/la-fda-de-ee-uu-presenta-aems-una-plataforma-unificada-para-la-notificacion-de-eventos-adversos-y-la-vigilancia-de-la-seguridad\/","og_locale":"es_ES","og_type":"article","og_title":"U.S. FDA Introduces AEMS: A Unified Platform for Adverse Event Reporting and Safety Surveillance","og_description":"Learn about the U.S. FDA's new AEMS platform for adverse event reporting and its impact on safety surveillance practices.","og_url":"https:\/\/regask.com\/es\/la-fda-de-ee-uu-presenta-aems-una-plataforma-unificada-para-la-notificacion-de-eventos-adversos-y-la-vigilancia-de-la-seguridad\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2026-03-19T08:44:56+00:00","article_modified_time":"2026-03-19T08:46:03+00:00","og_image":[{"width":800,"height":600,"url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/us-fda-introduces-aems-unified-platform-adverse-event-reporting-safety-surveillance.png","type":"image\/png"}],"author":"Reva Ananda","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Reva Ananda","Est. reading time":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/u-s-fda-introduces-aems-a-unified-platform-for-adverse-event-reporting-and-safety-surveillance\/#article","isPartOf":{"@id":"https:\/\/regask.com\/u-s-fda-introduces-aems-a-unified-platform-for-adverse-event-reporting-and-safety-surveillance\/"},"author":{"name":"Reva Ananda","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926"},"headline":"U.S. FDA Introduces AEMS: A Unified Platform for Advers&hellip;","datePublished":"2026-03-19T08:44:56+00:00","dateModified":"2026-03-19T08:46:03+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/u-s-fda-introduces-aems-a-unified-platform-for-adverse-event-reporting-and-safety-surveillance\/"},"wordCount":757,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/u-s-fda-introduces-aems-a-unified-platform-for-adverse-event-reporting-and-safety-surveillance\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/us-fda-introduces-aems-unified-platform-adverse-event-reporting-safety-surveillance.png","articleSection":["United States","Regulatory News","Food and Nutrition"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/regask.com\/u-s-fda-introduces-aems-a-unified-platform-for-adverse-event-reporting-and-safety-surveillance\/","url":"https:\/\/regask.com\/u-s-fda-introduces-aems-a-unified-platform-for-adverse-event-reporting-and-safety-surveillance\/","name":"La FDA de EE. UU. presenta AEMS: una revoluci\u00f3n en la presentaci\u00f3n de informes.","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/u-s-fda-introduces-aems-a-unified-platform-for-adverse-event-reporting-and-safety-surveillance\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/u-s-fda-introduces-aems-a-unified-platform-for-adverse-event-reporting-and-safety-surveillance\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/us-fda-introduces-aems-unified-platform-adverse-event-reporting-safety-surveillance.png","datePublished":"2026-03-19T08:44:56+00:00","dateModified":"2026-03-19T08:46:03+00:00","description":"Conozca la nueva plataforma AEMS de la FDA de EE. UU. para la notificaci\u00f3n de eventos adversos y su impacto en las pr\u00e1cticas de vigilancia de la seguridad.","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/u-s-fda-introduces-aems-a-unified-platform-for-adverse-event-reporting-and-safety-surveillance\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/u-s-fda-introduces-aems-a-unified-platform-for-adverse-event-reporting-and-safety-surveillance\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/us-fda-introduces-aems-unified-platform-adverse-event-reporting-safety-surveillance.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/us-fda-introduces-aems-unified-platform-adverse-event-reporting-safety-surveillance.png","width":800,"height":600,"caption":"Us Fda Introduces Aems Unified Platform Adverse Event Reporting Safety Surveillance"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"El sistema operativo de IA regulatoria para equipos de alto rendimiento","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/@RegASK","https:\/\/www.crunchbase.com\/organization\/regask","https:\/\/www.bloomberg.com\/profile\/company\/1691237D:SP","https:\/\/pitchbook.com\/profiles\/company\/265004-02","https:\/\/www.cbinsights.com\/company\/RegASK","https:\/\/vimeo.com\/RegASK"],"legalName":"RegASK PTE. LTD.","foundingDate":"2018","slogan":"Empowering Smarter Regulatory Decisions","description":"Plataforma de inteligencia regulatoria y orquestaci\u00f3n de flujos de trabajo con IA para ciencias de la vida y productos de consumo. RegASK combina modelos de negocio verticales, arquitectura de IA multiagente y una comunidad global de m\u00e1s de 1800 expertos para ofrecer an\u00e1lisis de horizontes regulatorios, an\u00e1lisis de impacto, automatizaci\u00f3n de flujos de trabajo de cumplimiento y resultados listos para auditor\u00edas en m\u00e1s de 160 pa\u00edses.","areaServed":"Worldwide","founder":{"@type":"Person","name":"Caroline Shleifer","jobTitle":"Founder & CEO"},"address":{"@type":"PostalAddress","streetAddress":"79 Science Park Drive, #06-01, Cintech IV","addressLocality":"Singapore","postalCode":"118264","addressCountry":"SG"},"contactPoint":{"@type":"ContactPoint","telephone":"+65 6817 6290","contactType":"customer service","availableLanguage":["English","French","Japanese","Spanish","Chinese","German"]},"numberOfEmployees":{"@type":"QuantitativeValue","minValue":50,"maxValue":100},"knowsAbout":["Regulatory Intelligence","Regulatory Compliance","Regulatory Affairs","Workflow Orchestration","Life Sciences Regulation","Consumer Products Regulation","AI-Driven Compliance"],"hasCertification":[{"@type":"Certification","name":"ISO\/IEC 42001:2023"},{"@type":"Certification","name":"ISO\/IEC 27001:2022"},{"@type":"Certification","name":"ISO\/IEC 27701"},{"@type":"Certification","name":"ISO\/IEC 27018:2019"},{"@type":"Certification","name":"SOC 2 Type II"}]},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926","name":"Reva Ananda"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/9682","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/users\/43"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/comments?post=9682"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/9682\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media\/9684"}],"wp:attachment":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media?parent=9682"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/categories?post=9682"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/tags?post=9682"}],"curies":[{"name":"Gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}